CsA@PLGA@GDD drug delivery system (DDS) was designed and prepared successfully.
The DDS released CsA at a stable rate for > 3 months.
The DDS kept filtration pathway unblocked for a longer time than control.
CsA@PLGA@GDD DDS prevented glaucoma scar formation as a safe and effective strategy.